SCHEMBL4333072

SCHEMBL4333072

CC(C)OC(Cc1cn(CCOC(=O)Nc2ccc(Cl)cc2)c2ccccc12)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 2/20 0.41
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
MAPT P10636 2/20 0.40
NPC1 O15118 1/20 0.40
GAA P10253 1/20 0.40
POLB P06746 1/20 0.40
KCNA5 P22460 2/20 0.40
BCHE P06276 2/20 0.40
KCNH2 Q12809 1/20 0.40
YES1 P07947 2/20 0.39
KDR P35968 2/20 0.39
JAK3 P52333 2/20 0.39
ALDH1A1 P00352 2/20 0.39
LMNA P02545 1/20 0.39
CNR2 P34972 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ADAM17 P78536 1/20 0.38
PLA2G4A P47712 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4341814 0.90 MAPT (0.48) MCL1MEN1KMT2AMAPTNPC1
SCHEMBL4333236 0.90 MEN1 (0.52) MEN1KMT2AMAPTNPC1POLB
SCHEMBL4335807 0.89 ADAM17 (0.40) MCL1MEN1KMT2AMAPTNPC1
SCHEMBL4329377 0.88 PPARG (0.39) MEN1KMT2AMAPTNPC1GAA
SCHEMBL4335595 0.83 MAPT (0.45) MEN1KMT2AMAPTPOLBALDH1A1
SCHEMBL13819345 0.81 KMT2A (0.53) KMT2AMAPTYES1KDRJAK3
SCHEMBL4338086 0.80 MEN1 (0.48) MEN1KMT2AMAPTNPC1POLB
SCHEMBL4341303 0.79 KMT2A (0.43) MEN1KMT2AMAPTNPC1POLB
SCHEMBL4333067 0.79 ADAM17 (0.45) MCL1KMT2AMAPTALDH1A1ADAM17
SCHEMBL4327192 0.78 CYP1A2 (0.56) MEN1KMT2AMAPTNPC1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 MCL1 3015/4885MEN1 4091/4885KMT2A 2774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.